# Dermata Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Feb 23, 2026

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-23
- Accepted by EDGAR: Feb 23, 2026, 19:56 ET
- Period: not reported
- Accession: 0001493152-26-007792
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226007792/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000149315226007792/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000149315226007792/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-007792. Last ingested by Listed: Nov 2, 2026, 18:37 ET. No prices; not investment advice.